P F Bonventre

Author PubWeight™ 87.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Shigella infection of Henle intestinal epithelial cells: role of the bacterium. Infect Immun 1979 5.24
2 Shigella infection of henle intestinal epithelial cells: role of the host cell. Infect Immun 1979 5.09
3 Studies on the mode of action of diphtheria toxin. I. Protein synthesis in guinea pig tissues. J Exp Med 1966 2.22
4 Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun 1983 2.08
5 Anomalous high native resistance to athymic mice to bacterial pathogens. Infect Immun 1977 1.75
6 Elimination of Leishmania donovani amastigotes by activated macrophages. Infect Immun 1981 1.58
7 Phagocytosis and intracellular killing of Staphylococcus aureus by normal mouse peritoneal macrophages. Infect Immun 1975 1.57
8 Enhanced metabolism of Leishmania donovani amastigotes at acid pH: an adaptation for intracellular growth. Science 1985 1.48
9 Studies on the mode of action of diphtheria toxin. III. Effect on subcellular components of protein synthesis from the tissues of intoxicated guinea pigs and rats. J Exp Med 1970 1.40
10 Chemical modulation of diphtheria toxin action on cultured mammalian cells. Infect Immun 1975 1.37
11 Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun 1985 1.36
12 A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages. J Immunol 1982 1.36
13 Interaction of cultured mammalian cells with [125I] diphtheria toxin. Infect Immun 1975 1.34
14 Lethal toxin of Bacillus cereus. I. Relationships and nature of toxin, hemolysin, and phospholipase. J Bacteriol 1967 1.32
15 The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med 1982 1.32
16 The effect of neutral and acidic polysaccharides on natural resistance of mice to bacterial challenge. J Infect Dis 1965 1.32
17 Studies on the mode of action of diphtheria toxin. II. Protein synthesis in primary heart cell cultures. J Exp Med 1967 1.31
18 Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun 1990 1.31
19 Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus. J Clin Microbiol 1984 1.31
20 Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis 1984 1.28
21 Autoradiographic evidence for the impermeability of mouse peritoneal macrophages to tritiated streptomycin. J Bacteriol 1967 1.27
22 Phagocytosis and intracellular disposition of viable bacteria by the isolated perfused rat liver. J Reticuloendothel Soc 1965 1.26
23 Status of bacterial toxins and their nomenclature: need for discipline and clarity of expression. Bacteriol Rev 1967 1.23
24 Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes. Antimicrob Agents Chemother 1978 1.20
25 Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages. J Immunol 1977 1.16
26 Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells. Infect Immun 1985 1.15
27 Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages. Infect Immun 1987 1.09
28 Facilitated uptake of streptomycin by Kupffer cells during phagocytosis. Nature 1967 1.09
29 Cell-mediated immune phenomena induced by lymphokines from splenic lymphocytes of mice with chronic staphylococcal infection. Infect Immun 1975 1.07
30 Inhibition of protein synthesis after intravenous or intramuscular challenge with diphtheria toxin. Infect Immun 1972 1.05
31 Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem. Antimicrob Agents Chemother 1988 1.04
32 Efficacy of combined immunostimulation and chemotherapy in experimental visceral Leishmaniasis. Am J Trop Med Hyg 1983 1.02
33 Cultural, phagocytic, and bactericidal characteristics of peritoneal macrophages. J Reticuloendothel Soc 1973 1.00
34 Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution. Protein Sci 1996 0.98
35 Evidence for pseudomonas exotoxin A receptors on plasma membrane of toxin-sensitive lm fibroblasts. Infect Immun 1984 0.97
36 Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody. Infect Immun 1988 0.96
37 Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model. Infect Immun 1995 0.96
38 Absorption of botulinal toxin from the gastrointestinal tract. Rev Infect Dis 1980 0.93
39 Studies on the mode of action of diphtheria toxin. V. Protein metabolism in a guinea pig model simulating chronic diphtheritic toxemia. Infect Immun 1973 0.93
40 Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infect Immun 1985 0.91
41 Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: T-lymphocyte-mediated immunosuppression. Infect Immun 1985 0.90
42 Augmentation of glucose transport in macrophages after particle ingestion. Infect Immun 1974 0.90
43 Specificity of diphtheria toxin action on heart and muscle tissues of Guinea pigs. Infect Immun 1970 0.89
44 Studies on the effect of diphtheria toxin on protein synthesis in mice. J Med Microbiol 1973 0.89
45 Toxic shock syndrome: a microbiological perspective. Surv Synth Pathol Res 1984 0.88
46 Specific reversal of diphtheria toxin mediated inhibition of protein synthesis in guinea pig tissues. Biochem Biophys Res Commun 1970 0.87
47 Immunosuppression associated with visceral leishmaniasis of hamsters. Parasite Immunol 1985 0.87
48 Enzymes of carbohydrate metabolism in Leishmania donovani amastigotes. J Protozool 1984 0.86
49 Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity. J Reticuloendothel Soc 1982 0.86
50 Uptake of diphtheria toxin and its fragment A moiety by mammalian cells in culture. Infect Immun 1976 0.85
51 Estimate of myocardial damage induced by diphtheria toxin. J Lab Clin Med 1973 0.85
52 Staphylococcal enterotoxins fail to disrupt membrane integrity or synthetic functions of Henle 407 intestinal cells. Infect Immun 1981 0.84
53 Specific receptor binding of staphylococcal enterotoxins by murine splenic lymphocytes. Infect Immun 1981 0.84
54 Familial hypersensitivity pneumonitis induced by Bacillus subtilis. Am Rev Respir Dis 1980 0.84
55 Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines. J Med Microbiol 1981 0.84
56 Endotoxin enhancement of toxic shock syndrome toxin 1-induced secretion of interleukin 1 by murine macrophages. Rev Infect Dis 1989 0.83
57 Membrane transport by mouse and guinea pig macrophages: characteristics of the glucose transport system. J Reticuloendothel Soc 1975 0.82
58 Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells. Infect Immun 1995 0.81
59 Impaired resistance to bacterial infection after tumor implant is traced to lactic dehydrogenase virus. Infect Immun 1980 0.80
60 Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1). Am J Trop Med Hyg 1985 0.80
61 Membrane transport by guinea pig peritoneal exudate leukocytes: effect of phagocytosis on hexose and amino acid transport. J Cell Physiol 1977 0.80
62 Studies on the mode of action of diphtheria toxin. VI. Inhibition of protein synthesis induced by local infection with toxingenic Corynebacterium diphtheriae. Proc Soc Exp Biol Med 1973 0.80
63 Kinetics of phagocytosis and killing of E. coli by murine macrophages in presence of different serum preparations. Microbiologica 1988 0.80
64 Membrane transport of amino acids and hexose by guinea pig and mouse phagocytes. J Reticuloendothel Soc 1977 0.80
65 A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation. Infect Immun 1995 0.79
66 The localization of Staphylococcus aureus in mice by whole-animal radioautography. Am J Pathol 1966 0.79
67 Passive protection of rabbits infected with toxic shock syndrome-associated strains of Staphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1. Rev Infect Dis 1989 0.79
68 Leishmania donovani infection in athymic mice derived from parental strains of the susceptible (Lshs) or resistant (Lshr) phenotype. J Leukoc Biol 1984 0.78
69 Attempts to implicate the central nervous system as a primary site of action for Bacillus anthracis lethal toxin. Fed Proc 1967 0.78
70 Staphylococcal enterotoxin induced mitogenesis: toxin binding and cell-cell interactions. Microbiologica 1983 0.78
71 Interaction of toxin of Corynebacterium diphtheriae with phagocytes from susceptible and resistant species. J Infect Dis 1975 0.78
72 Activation of in vitro proliferation of human T cells by a synthetic peptide of toxic shock syndrome toxin 1. J Infect Dis 1991 0.77
73 Effects of solid tumors on the resistance of mice to viral and bacterial infections. Proc Soc Exp Biol Med 1982 0.77
74 A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice. Pathobiology 1995 0.76
75 Cyclosporin A treatment converts Leishmania donovani-infected C57BL/10 (curing) mice to a noncuring phenotype. Infect Immun 1990 0.76
76 Immunoblots for detection of toxic shock syndrome toxin 1 produced by Staphylococcus aureus. J Clin Microbiol 1990 0.75
77 Carboxymethylcellulose, tampons, and staphylococci. Lancet 1983 0.75
78 Acquired cellular resistance following transfer of lymphocytes from mice infected repeatedly with Staphylococcus aureus. Cell Immunol 1976 0.75
79 Killing of Leishmania donovani. Amastigotes by murine macrophages. Adv Exp Med Biol 1982 0.75
80 Effects of toxic shock syndrome toxin-1 and a site-directed mutant, H135A, in mice. Adv Exp Med Biol 1996 0.75
81 Thioglycollate elicited macrophages demonstrate enhanced virus replication and depressed bacterial killing. Microbiologica 1987 0.75
82 Effects of monoclonal antibody on biologic function of toxic shock syndrome toxin 1 in vitro and in vivo. Rev Infect Dis 1989 0.75
83 Relationship of superabsorbant tampons and the toxic shock syndrome. Am J Obstet Gynecol 1984 0.75
84 Studies on the mode of action of diphtheria toxin. Protein synthesis in guinea pig tissues and primary heart cell cultures. Ann Ist Super Sanita 1968 0.75
85 Intraphagocytic activity of imipenem and piperacillin. J Antimicrob Chemother 1988 0.75
86 Inhibition of ovulation in hamsters by the protein synthesis inhibitors diphtheria toxin and cycloheximide. Proc Soc Exp Biol Med 1979 0.75